Frontiers in Neurology (Mar 2022)

Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults With Neuropathic Pain After Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials

  • Hai-Qian Ling,
  • Hai-Qian Ling,
  • Hai-Qian Ling,
  • Hai-Qian Ling,
  • Zi-Hao Chen,
  • Zi-Hao Chen,
  • Zi-Hao Chen,
  • Lei He,
  • Lei He,
  • Lei He,
  • Feng Feng,
  • Feng Feng,
  • Feng Feng,
  • Chuang-Gui Weng,
  • Chuang-Gui Weng,
  • Chuang-Gui Weng,
  • Si-Jin Cheng,
  • Si-Jin Cheng,
  • Si-Jin Cheng,
  • Li-Min Rong,
  • Li-Min Rong,
  • Li-Min Rong,
  • Pei-Gen Xie,
  • Pei-Gen Xie,
  • Pei-Gen Xie

DOI
https://doi.org/10.3389/fneur.2022.818522
Journal volume & issue
Vol. 13

Abstract

Read online

ObjectiveTo provide an updated analysis of the efficacy and safety of drugs for the management of neuropathic pain (NP) after spinal cord injury (SCI) based on Bayesian network analysis.MethodsA Bayesian network meta-analysis of literature searches within PubMed, Cochrane Library, Embase, and Web of Science databases from their inception to February 21 2021 was conducted without language restrictions. Paired and network meta-analyses of random effects were used to estimate the total standardized mean deviations (SMDs) and odds ratios (ORs).ResultsA total of 1,133 citations were identified and 20 RCTs (including 1,198 patients) involving 11 drugs and placebos for post-SCI NP selected. The 5 outcomes from all 11 drugs and placebos had no inconsistencies after Bayesian network analysis. BTX-A gave the most effective pain relief for the 4 weeks, following a primary outcome. No significant differences were found among drugs with regard to adverse events of the primary outcome. Gabapentin, BTX-A, and pregabalin were found to be the most helpful in relieving secondary outcomes of mental or sleep-related symptoms with differences in SMDs, ranging from −0.63 to −0.86. Tramadol triggered more serious adverse events than any of the other drugs with differences in ORs ranging from 0.09 to 0.11.ConclusionBTX-A, gabapentin, pregabalin, amitriptyline, ketamine, lamotrigine, and duloxetine were all effective for NP management following SCI. Lamotrigine and gabapentin caused fewer side effects and had better efficacy in relieving mental or sleep-related symptoms caused by SCI-related NP. Tramadol, levetiracetam, carbamazepine, and cannabinoids could not be recommended due to inferior safety or efficacy.Systematic Review Registration[https://inplasy.com/inplasy-2020-7-0061/], identifier [INPLASY202070061].

Keywords